Hygiena 2018, 63(3):99-104 | DOI: 10.21101/hygiena.a1585

Selected environmental risk factors of inflammatory bowel diseases

Jana Diabelková
Univerzita Pavla Jozefa Šafárika, Lekárska fakulta, Ústav verejného zdravotníctva a hygieny, Košice, Slovenská republika

The incidence of inflammatory bowel disease has increased in recent years, but the exact cause of the disease is not yet clear and therefore we do not know of any reliable way of prevention. Described is current knowledge about the role and influence of selected risk factors related to the development, relapse and progression of inflammatory bowel disease. More specifically, it deals with potential risk factors such as hygiene, smoking, environment, sanitation, industrialization and socio-economic status, air pollution, water, but also the role of intestinal microbioma, infections, antibiotic use, and stress and sleep. Highlighted is the need to clarify the aetiology of the disease.

Keywords: infectious bowel diseases, ulcerative colitis, Crohn's disease, environmental risk factors

Published: September 30, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Diabelková J. Selected environmental risk factors of inflammatory bowel diseases. Hygiena. 2018;63(3):99-104. doi: 10.21101/hygiena.a1585.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Russell RK, Satsangi J. Does IBD run in families? Inflamm Bowel Dis. 2008 Oct;14 Suppl 2:S20-1. Go to original source... Go to PubMed...
    2. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cézard JP, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001 May 31;411(6837):599-603. Go to original source... Go to PubMed...
    3. Ek WE, D'Amato M, Halfvarson J. The history of genetics in inflammatory bowel disease. Ann Gastroenterol. 2014;27(4):294-303. Go to PubMed...
    4. Lakatos L, Mester G, Erdelyi Z, Balogh M, Szipocs I, Kamaras G, et al. Striking elevation in incidence and prevalence of inflammatory bowel disease in a province of western Hungary between 1977-2001. World J Gastroenterol. 2004 Feb 1;10(3):404-9. Go to original source... Go to PubMed...
    5. Wild CP. Complementing the genome with an "exposome": the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers Prev. 2005 Aug;14(8):1847-50. Go to original source... Go to PubMed...
    6. Wild CP. The exposome: from concept to utility. Int J Epidemiol. 2012 Feb;41(1):24-32. Go to original source... Go to PubMed...
    7. Strachan DP. Hay fever, hygiene, and household size. BMJ. 1989 Nov 18;299(6710):1259-60. Go to original source... Go to PubMed...
    8. Noverr MC, Huffnagle GB. The 'microflora hypothesis' of allergic diseases. Clin Exp Allergy. 2005 Dec;35(12):1511-20. Go to original source... Go to PubMed...
    9. Leong RW, Mitrev N, Ko Y. Hygiene Hypothesis: is the evidence the same all over the world? Dig Dis. 2016 Mar;34(1-2):35-42. Go to original source... Go to PubMed...
    10. Mahid SS, Minor KS, Soto RE, Hornung CA, Galandiuk S. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc. 2006 Nov;81(11):1462-71. Go to original source... Go to PubMed...
    11. Johnson GJ, Cosnes J, Mansfield JC. Review article: smoking cessation as primary therapy to modify the course of Crohn's disease. Aliment Pharmacol Ther. 2005 Apr 15;21(8):921-31. Go to original source... Go to PubMed...
    12. Cosnes J, Beaugerie L, Carbonnel F, Gendre JP. Smoking cessation and the course of Crohn's disease: an intervention study. Gastroenterology. 2001 Apr;120(5):1093-9. Go to original source... Go to PubMed...
    13. Biedermann L, Fournier N, Misselwitz B, Frei P, Zeitz J, Manser CN, et al ; Swiss Inflammatory Bowel Disease Cohort Study Group. High rates of smoking especially in female Crohn's disease patients and low use of supportive measures to achieve smoking cessation - Data from the SwissIBD cohort study. J Crohns Colitis. 2015 Oct;9(10):819-29. Go to original source... Go to PubMed...
    14. Nunes T, Etchevers MJ, García-Sánchez V, Ginard D, Martí E, Barreiro-de Acosta M, et al. Impact of smoking cessation on the clinical course of Crohn's disease under current therapeutic algorithms: a multicenter prospective study. Am J Gastroenterol. 2016 Mar;111(3):411-9. Go to original source... Go to PubMed...
    15. Boyko EJ, Koepsell TD, Perera DR, Inui TS. Risk of ulcerative colitis among former and current cigarette smokers. N Engl J Med. 1987 Mar 19;316(12):707-10. Go to original source... Go to PubMed...
    16. Higuchi LM, Khalili H, Chan AT, Richter JM, Bousvaros A, Fuchs CS. A prospective study of cigarette smoking and the risk of inflammatory bowel disease in women. Am J Gastroenterol. 2012 Sep;107(9):1399-406. Go to original source... Go to PubMed...
    17. Boyko EJ, Perera DR, Koepsell TD, Keane EM, Inui TS. Effects of cigarette smoking on the clinical course of ulcerative colitis. Scand J Gastroenterol. 1988 Nov;23(9):1147-52. Go to original source... Go to PubMed...
    18. Ye Y, Pang Z, Chen W, Ju S, Zhou C. The epidemiology and risk factors of inflammatory bowel disease. Int J Clin Exp Med. 2015 Dec 15;8(12):22529-42.
    19. Höie O, Wolters F, Riis L, Aamodt G, Solberg C, Bernklev T, et al; European Collaborative Study Group of Inflammatory Bowel Disease. Ulcerative colitis: patient characteristics may predict 10-yr disease recurrence in a European-wide population-based cohort. Am J Gastroenterol. 2007 Aug;102(8):1692-701. Go to original source... Go to PubMed...
    20. Benchimol EI, Mack DR, Guttmann A, Nguyen GC, To T, Mojaverian N, et al. Inflammatory bowel disease in immigrants to Canada and their children: a population-based cohort study. 2015 Apr;110(4):553-63. Go to original source... Go to PubMed...
    21. Nerich V, Monnet E, Weill A, Vallier N, Vanbockstael V, Auleley GR, et al. Fine-scale geographic variations of inflammatory bowel disease in France: correlation with socioeconomic and house equipment variables. Inflamm Bowel Dis. 2010 May;16(5):813-21. Go to original source... Go to PubMed...
    22. Hu D, Ren J, Wang G, Gu G, Liu S, Wu X, et al. Geographic mapping of Crohn's disease and its relation to affluence in Jiangsu province, an eastern coastal province of China. Gastroenterol Res Pract. 2014 Apr;2014:590467. Go to original source... Go to PubMed...
    23. Salim SY, Kaplan GG, Madsen KL. Air pollution effects on the gut microbiota: a link between exposure and inflammatory disease. Gut Microbes. 2014 Mar-Apr;5(2):215-9. Go to original source... Go to PubMed...
    24. Ananthakrishnan AN, McGinley EL, Binion DG, Saeian K. Ambient air pollution correlates with hospitalizations for inflammatory bowel disease: an ecologic analysis. Inflamm Bowel Dis. 2011 May;17(5):1138-45. Go to original source... Go to PubMed...
    25. Masuyama H, Hiramatsu Y, Kunitomi M, Kudo T, MacDonald PN. Endocrine disrupting chemicals, phthalic acid and nonylphenol, activate Pregnane X receptor-mediated transcription. Mol Endocrinol. 2000 Mar;14(3):421-8. Go to original source... Go to PubMed...
    26. Dominguez-Bello MG, Blaser MJ, Ley RE, Knight R. Development of the human gastrointestinal microbiota and insights from high-throughput sequencing. Gastroenterology. 2011 May;140(6):1713-9. Go to original source... Go to PubMed...
    27. Scanlan PD, Shanahan F, O'Mahony C, Marchesi JR. Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn's disease. J Clin Microbiol. 2006 Nov;44(11):3980-8. Go to original source... Go to PubMed...
    28. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermúdez-Humarán LG, Gratadoux JJ, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA. 2008 Oct 28;105(43):16731-6. Go to original source... Go to PubMed...
    29. Rajca S, Grondin V, Louis E, Vernier-Massouille G, Grimaud JC, Bouhnik Y, et al. Alterations in the intestinal microbiome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn's disease. Inflamm Bowel Dis. 2014 Jun;20(6):978-86. Go to original source... Go to PubMed...
    30. Zhou L, Lopes JE, Chong MM, Ivanov II, Min R, Victora GD, et al. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature. 2008 May 8;453(7192):236-40. Go to original source... Go to PubMed...
    31. Jodorkovsky D, Young Y, Abreu MT. Clinical outcomes of patients with ulcerative colitis and co-existing Clostridium difficile infection. Dig Dis Sci. 2010 Feb;55(2):415-20. Go to original source... Go to PubMed...
    32. Wang W, Jovel J, Halloran B, Wine E, Patterson J, Ford G, et al. Metagenomic analysis of microbiome in colon tissue from subjects with inflammatory bowel diseases reveals interplay of viruses and bacteria. Inflamm Bowel Dis. 2015 Jun;21(6):1419-27. Go to original source... Go to PubMed...
    33. Ramanan D, Bowcutt R, Lee SC, Tang MS, Kurtz ZD, Ding Y, et al. Helminth infection promotes colonization resistance via type 2 immunity. Science. 2016 Apr 29;352(6285):608-12. Go to original source... Go to PubMed...
    34. Garg SK, Croft AM, Bager P. Helminth therapy (worms) for induction of remission in inflammatory bowel disease. Cochrane Database Syst Rev. 2014 Jan 20;(1):CD009400. Go to original source... Go to PubMed...
    35. Ungaro R, Bernstein CN, Gearry R, Hviid A, Kolho KL, Kronman MP, et al. Antibiotics associated with increased risk of new-onset Crohn's disease but not ulcerative colitis: a meta-analysis. Am J Gastroenterol. 2014 Nov;109(11):1728-38. Go to original source... Go to PubMed...
    36. Khan KJ, Ullman TA, Ford AC, Abreu MT, Abadir A, Marshall JK, et al. Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol. 2011 Apr;106(4):661-73. Go to original source... Go to PubMed...
    37. Rutgeerts P, Van Assche G, Vermeire S, D'Haens G, Baert F, Noman M, et al. Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial. Gastroenterology. 2005 Apr;128(4):856-61. Go to original source... Go to PubMed...
    38. Sternberg EM, Chrousos GP, Wilder RL, Gold PW. The stress response and the regulation of inflammatory disease. Ann Intern Med. 1992 Nov;117(10):854-66. Go to original source... Go to PubMed...
    39. Boye B, Lundin KE, Jantschek G, Leganger S, Mokleby K, Tangen T, et al. INSPIRE study: does stress management improve the course of inflammatory bowel disease and disease-specific quality of life in distressed patients with ulcerative colitis or Crohn's disease? A randomized controlled trial. Inflamm Bowel Dis. 2011 Sept;17(9):1863-73. Go to original source... Go to PubMed...
    40. Timmer A, Preiss JC, Motschall E, Rücker G, Jantschek G, Moser G. Psychological interventions for treatment of inflammatory bowel disease. Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006913. Go to original source... Go to PubMed...
    41. Zisapel N. Sleep and sleep disturbances: biological basis and clinical implications. Cell Mol Life Sci. 2007 May;64(10):1174-86. Go to original source... Go to PubMed...
    42. Ali T, Orr WC. Sleep disturbances and inflammatory bowel disease. Inflamm Bowel Dis. 2014 Nov;20(11):1986-95. Go to original source... Go to PubMed...
    43. Ananthakrishnan AN, Long MD, Martin CF, Sandler RS, Kappelman MD. Sleep disturbance and risk of active disease in patients with Crohn's disease and ulcerative colitis. Clin Gastroenterol Hepatol. 2013 Aug;11(8):965-71. Go to original source... Go to PubMed...
    44. Graff LA, Vincent N, Walker JR, Clara I, Carr R, Ediger J, et al. A population-based study of fatigue and sleep difficulties in inflammatory bowel disease. Inflamm Bowel Dis. 2011 Sept;17(9):1882-9. Go to original source... Go to PubMed...

    Return to the content